|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/7052 | (2006.01) |
| A61K 38/21 | (2006.01) | ||
| C12Q 1/70 | (2006.01) | ||
| C12Q 1/04 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 1576138 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03796412.9 |
| Date of filing the European patent application | 2003-11-17 | |
| (97) | Date of publication of the European application | 2005-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation | 2017-06-26 |
| (86) | Number | PCT/US2003/036714 |
| Date | 2003-11-17 |
| (87) | Number | WO 2004/046331 |
| Date | 2004-06-03 |
| (30) | Number | Date | Country code |
| 426675 P | 2002-11-15 | US |
| (72) |
SOMMADOSSI, Jean-Pierre, US
LA COLLA, Paolo, IT
STANDRING, David, US
BICHKO, Vadim, US
QU, Lin, US
|
| (73) |
Idenix Pharmaceuticals LLC,
320 Bent Street, Floor 4, Cambridge, MA 02141,
US
Universitą Degli Studi di Cagliari, Via Universitą n. 40, 09124 Cagliari, IT |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 2`-Šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija |
| 2`-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION |
| Payment date | Validity (years) | Amount | |
| 2018-11-07 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-03-21 |